Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Rich-Henry Schabowsky"'
Autor:
Shravan Madireddi, Rich-Henry Schabowsky, Abhishek K Srivastava, Rajesh K Sharma, Esma S Yolcu, Haval Shirwan
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e42459 (2012)
Tumors convert conventional CD4(+) T cells into induced CD4(+)CD25(+)FoxP3(+) T regulatory (iTreg) cells that serve as an effective means of immune evasion. Therefore, the blockade of conventional CD4(+) T cell conversion into iTreg cells represents
Externí odkaz:
https://doaj.org/article/03fd0d640d6b4ef39ad5c2f5b979e537
Autor:
Shravan Madireddi, Rich-Henry Schabowsky, Abhishek K. Srivastava, Rajesh K. Sharma, Esma S. Yolcu, Haval Shirwan
Publikováno v:
PLoS ONE, Vol 7, Iss 8 (2012)
Externí odkaz:
https://doaj.org/article/cf6e3a759b8741649e2cb91c16cb23b1
Autor:
Haval Shirwan, Esma S. Yolcu, Kathryn J. MacLeod, Robert W. Miller, Zhenping Zhong, Hong Zhao, Shravan Madireddi, Kutlu G. Elpek, Abhishek K. Srivastava, Rich-Henry Schabowsky, Rajesh K. Sharma
Supplementary Figures 1-5, Methods from 4-1BB Ligand as an Effective Multifunctional Immunomodulator and Antigen Delivery Vehicle for the Development of Therapeutic Cancer Vaccines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d862589cdd94ed5132c29996098a81d
https://doi.org/10.1158/0008-5472.22381974.v1
https://doi.org/10.1158/0008-5472.22381974.v1
Autor:
Haval Shirwan, Esma S. Yolcu, Kathryn J. MacLeod, Robert W. Miller, Zhenping Zhong, Hong Zhao, Shravan Madireddi, Kutlu G. Elpek, Abhishek K. Srivastava, Rich-Henry Schabowsky, Rajesh K. Sharma
Therapeutic subunit vaccines based on tumor-associated antigens (TAA) represent an attractive approach for the treatment of cancer. However, poor immunogenicity of TAAs requires potent adjuvants for therapeutic efficacy. We recently proposed the tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e901b4db577ef7712b6cd2fb033b0f8
https://doi.org/10.1158/0008-5472.c.6500049.v1
https://doi.org/10.1158/0008-5472.c.6500049.v1
Autor:
Haval Shirwan, Laura Bandura-Morgan, Hong Zhao, Rich-Henry Schabowsky, Esma S. Yolcu, Kutlu G. Elpek, Rajesh K. Sharma
Supplementary Methods, Figures 1-5, Table 1 from Costimulation as a Platform for the Development of Vaccines: A Peptide-Based Vaccine Containing a Novel Form of 4-1BB Ligand Eradicates Established Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b5e67f18e8a84db7f3d6e5b55aa9d5
https://doi.org/10.1158/0008-5472.22377432
https://doi.org/10.1158/0008-5472.22377432
Autor:
Esma S. Yolcu, Rich-Henry Schabowsky, Kutlu G. Elpek, Hong Zhao, Rajesh K. Sharma, Laura Bandura-Morgan, Haval Shirwan
Publikováno v:
Cancer Research. 69:4319-4326
Vaccines represent an attractive treatment modality for the management of cancer primarily because of their specificity and generation of immunologic memory important for controlling recurrences. However, the efficacy of therapeutic vaccines may requ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5937d7dc5a61238e5683beb115443679
https://doi.org/10.1158/0008-5472.can-08-3141
https://doi.org/10.1158/0008-5472.can-08-3141
Autor:
Esma S. Yolcu, Rich-Henry Schabowsky, Kutlu G. Elpek, Deanna D. H. Franke, Haval Shirwan, Chantale Lacelle
Publikováno v:
The Journal of Immunology. 179:7295-7304
Naturally occurring CD4+CD25+FoxP3+ T regulatory (Treg) cells require three distinct signals transduced via TCR, CD28, and IL-2R for their development and maintenance. These requirements served as the basis for several recently developed ex vivo expa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d74557d299a5f12d4e55316356a295a4
https://doi.org/10.4049/jimmunol.179.11.7295
https://doi.org/10.4049/jimmunol.179.11.7295
Autor:
Shravan Madireddi, Rich-Henry Schabowsky, Abhishek K. Srivastava, Rajesh K. Sharma, Esma S. Yolcu, Haval Shirwan
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 8 (2012)
PLoS ONE, Vol 7, Iss 8 (2012)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76b1a145a1778e621f6a4572de102cff
http://europepmc.org/articles/PMC3425595
http://europepmc.org/articles/PMC3425595
Autor:
Abhishek K. Srivastava, Esma S. Yolcu, Haval Shirwan, Rajesh K. Sharma, Rich-Henry Schabowsky, Shravan Madireddi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 8, p e42459 (2012)
PLoS ONE, Vol 7, Iss 8, p e42459 (2012)
Tumors convert conventional CD4(+) T cells into induced CD4(+)CD25(+)FoxP3(+) T regulatory (iTreg) cells that serve as an effective means of immune evasion. Therefore, the blockade of conventional CD4(+) T cell conversion into iTreg cells represents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de20d3872cc4ce4aecdd2c4558e2aa6d
http://europepmc.org/articles/PMC3411638
http://europepmc.org/articles/PMC3411638
Autor:
Haval Shirwan, Kathryn J. MacLeod, Rich-Henry Schabowsky, Abhishek K. Srivastava, Rajesh K. Sharma, Esma S. Yolcu, Shravan Madireddi
Cervical cancer is the leading cause of cancer-related deaths among women worldwide. Current prophylactic vaccines based on HPV (Human papillomavirus) late gene protein L1 are ineffective in therapeutic settings. Therefore, there is an acute need for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1f715cb4a844ed30c779c9096f83c67
https://europepmc.org/articles/PMC2921468/
https://europepmc.org/articles/PMC2921468/